Confirm the intended product
A shared active ingredient can appear across products with different labeling, indications, strengths and market status.
Active ingredient comparison
Denosumab appears in 4 brand or manufacturer-labeled product profiles in the US Med Access catalog, covering 12 dated package references. European estimated medicine cost references currently range from €2,605.20 – €2,915.07. A shared ingredient does not make different products, strengths, dosage forms or packages interchangeable.
Multi-product ingredient index
Open the exact profile before comparing figures. Brand, manufacturer, authorization, dosage form, strength and package quantity can differ even when the named active ingredient is the same.
| Brand or product | Category | Packages | European reference | Comparable U.S. cash | Profile |
|---|---|---|---|---|---|
| OsenveltCelltrion Healthcare Deutschland GmbH | Rare Disease | 1 | €2,605.20 | Not listed | Open profile → |
| XbrykSamsung Bioepis NL B.V. | Immunology | 1 | €2,726.38 | Not listed | Open profile → |
| XgevaMultiple EU-listed suppliers | Oncology | 9 | €2,782.91 to €2,915.07 | Not listed | Open profile → |
| YaxwerSun Pharmaceuticals Germany GmbH | Immunology | 1 | €2,726.38 | Not listed | Open profile → |
How to use this page
Open each product profile and match the intended brand, manufacturer, strength, dosage form and package quantity. Only compare cost references after the products are meaningfully comparable.
A shared active ingredient can appear across products with different labeling, indications, strengths and market status.
Compare equivalent quantities and retain the original package description beside any unit-level calculation.
Price, availability, source status, exchange rates and route requirements can change after publication.
Product-specific review
Share the intended brand, strength, dosage form, quantity, destination and organization type. No substitution, supply or import outcome is guaranteed.